Inactivation of α-chymotrypsin by a bifunctional reagent, 2-bromomethyl-3,1-benzoxazin-4-one
-
Add time:07/16/2019 Source:sciencedirect.com
α-Chymotrypsin is selectively and irreversibly inactivated by 2-bromomethyl-3,i-benzoxazin-4-one (Compd Ib) at neutral pH. Reaction of the enzyme with this activated ester leads rapidly to a relatively stable acyl-enzyme in which intramolecular alkylation of a single methionine residue (likely methionine-192) followed by hydrolysis of the acyl-enzyme bond occurs. Kinetic evidence for such a process is found in the measurements of proflavin displacement accompanying the reaction. The irreversibly modified enzyme still possesses its intact active site but its activity towards specific substrates is altered. Alkylation of the enzyme increases mainly Km but does not change appreciably kcat. The inhibition constants of specific inhibitors such as proflavin or indole are increased several times. From crystallographic data it is known that methionine-192 forms the lid of the specificity cavity in the enzyme. Therefore a bulky substituent such as the 2-acetamido benzoic acid on the sulfur atom of this methionine might sterically hinder the substrate binding by blocking the approach of the binding site.
We also recommend Trading Suppliers and Manufacturers of 4-(bromomethyl)-3-(trifluoromethyl)benzoic acid (cas 859213-39-1). Pls Click Website Link as below: cas 859213-39-1 suppliers
Prev:Design, synthesis, and biological evaluation of deuterated phenylpropionic acid derivatives as potent and long-acting free fatty acid receptor 1 agonists
Next:Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity07/17/2019
- Design, synthesis, and biological evaluation of deuterated phenylpropionic acid derivatives as potent and long-acting free fatty acid receptor 1 agonists07/15/2019
- Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid07/14/2019
- Further optimization of sulfonamide analogs as EP1 receptor antagonists: Synthesis and evaluation of bioisosteres for the carboxylic acid group07/13/2019
- Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists07/12/2019
- Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists07/11/2019
-
Health and Chemical more >


